Use of threonine for the treatment of phenylketonuria
OwnerGilda Georgi, Gunther Sawatzkiinventors
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of threonine for the treatment of phenylketonuria. The invention is based on the surprising discovery that the concentration of phenylalanine in the plasma of PKU patients can be reduced by additional doses of threonine. The object of the invention is therefore an composition for dietetic or pharmaceutical use in phenylketonuria, which composition contains at least 8 g threonine per 100 g amino acids. This composition may consist of foods, in particular formula foods and PKU dietetic products.
Claims8
Composition for the dietetic or pharmaceutical treatment of phenylketonuria,
- characterised by
- a content of at least 8 g threonine per 100 g amino acids.
Use of threonine for the treatment of phenylketonuria or for lowering the phenyl-alanine level in the plasma.
Process for the treatment of PKU, wherein an additional amount of threonine is administered to a PKU patient, as well as the amount of threonine which the PKU patient usually or normally ingests.
Dependencies are inferred from the claim text.